Eli Lilly Stock: Overvalued - Plain And Simple (NYSE:LLY)
Eli Lilly has several products with growth potential and Mounjaro could reach blockbuster status. See why LLY stock remains a Sell for the next few years.
Eli Lilly Stock: Overvalued - Plain And Simple (NYSE:LLY)
Eli Lilly has several products with growth potential and Mounjaro could reach blockbuster status. See why LLY stock remains a Sell for the next few years.